Neda Sofarzadeh
Vice President, Head of Investor Relations, Public Relations, and Marketing
Replay available
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2025 Earnings Call
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) Q1 2025 earnings conference call, held 2025-05-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joe Payne
President and CEO
Andy Sassine
Chief Financial Officer
Yasmeen Remy
Analyst, Piper Sandler
Lily Sanago
Analyst, Lee Rink Partners
Evan Wang
Analyst, Guggenheim Securities
Whitney Ijem
Analyst, Kin Accord
Tom Schrader
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Arcturus Therapeutics Holdings Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.057 Today's call is being recorded. I would now like to turn the call over to Neda Sofarzadeh, 00:00:05.057 -- 00:00:09.302 Vice President, Head of Investor Relations, Public Relations, and Marketing. 00:00:09.302 -- 00:00:11.703 Please go ahead. 00:00:11.905 -- 00:00:17.452 Thank you, Operator. Good afternoon and welcome to ArcTera Therapeutics quarterly financial 00:00:17.452 -- 00:00:23.039 update and pipeline progress call. Today's call will be led by Joe Payne, our President 00:00:23.039 -- 00:00:28.518 and CEO, and Andy Sassine, our CFO. Dr. Pat Srivukula, our CSO 00:00:28.518 -- 00:00:32.582 and COO, will join them for the Q&A session. 00:00:32.582 -- 00:00:37.286 Before we begin, I would like to remind everyone that the statements made during this 00:00:37.286 -- 00:00:42.891 call regarding matters that are not historical facts are forward-looking statements 00:00:42.891 -- 00:00:48.135 within the safe harbor provisions of the Private Securities Litigation Reform Act 00:00:48.135 -- 00:00:51.096 of 1995. Forward-looking 00:00:51.739 -- 00:00:54.875 statements are not guarantees of performance. 00:00:54.875 -- 00:00:59.922 They involve known and unknown risks, uncertainties, and assumptions that 00:00:59.922 -- 00:01:05.310 may cause actual results, performance, and achievements to differ materially 00:01:05.310 -- 00:01:09.996 from those expressed or implied by the statement. 00:01:09.996 -- 00:01:14.563 Please see the forward-looking statement disclaimer on the company's press release issued 00:01:14.563 -- 00:01:20.150 earlier today, as well as the risk factor section in our most recent form, 00:01:20.150 -- 00:01:24.473 10-K, and in subsequent filings with the SEC. 00:01:24.473 -- 00:01:29.839 In addition, any forward-lookin...